• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Correspondence
Correspondence on editorial regarding “Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?”
Young Eun Chon1, Dong Yun Kim2, Hong Jae Chon3, Do Young Kim2
1Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
3Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
Correspondence :  Hong Jae Chon ,
Tel: +82-31-780-5210, Email: minidoctor@cha.ac.kr
Do Young Kim ,
Tel: 82-2-2228-1930, Fax: 82-2-393-1395, Email: dyk1025@yuhs.ac
Received: May 24, 2024   Accepted: May 29, 2024
*Young Eun Chon and Dong Yun Kim contributed equally to this work.
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 301 View
  • 14 Download
Related articles

Correspondence on Editorial regarding “Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: a gateway to personalized medicine”

Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?

Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”2024 January;30(1)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”2023 January;29(1)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1339
TOTAL : 1896034
Close layer